Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
about
Porcine PD-L1: cloning, characterization, and implications during xenotransplantationAn essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cellsInvolvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.No evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activationGenes, tolerance and systemic autoimmunityThe PD-1 pathway in tolerance and autoimmunityRole of PD-1 in HIV pathogenesis and as target for therapyActive systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) miceSustained activation of Lyn tyrosine kinase in vivo leads to autoimmunityMolecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interactionEngagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationPD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cellsMelanoma immunotherapy dominates the fieldNew targeted treatments for non-small-cell lung cancer - role of nivolumabCurrent status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapyThe immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpointsRole of the tumor microenvironment in mature B-cell lymphoid malignanciesCurrent status of immunotherapyNovel immunotherapies in lymphoid malignanciesProgrammed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapyHuman Cancer Immunotherapy with PD-1/PD-L1 BlockadePembrolizumabNivolumab in the treatment of malignant melanoma: review of the literatureImmunotherapy of Ovarian Cancer: The Role of Checkpoint InhibitorsRole of the PD-1 pathway in the immune responseThe programmed death-1 immune-suppressive pathway: barrier to antitumor immunityImmune Checkpoint Blockade in Cancer TherapyRole of immunotherapy for renal cell cancer in 2011From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsPD-1 as an emerging therapeutic target in renal cell carcinoma: current evidenceRegulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological DisordersTo affinity and beyond: harnessing the T cell receptor for cancer immunotherapyImmunoregulatory molecules are master regulators of inflammation during the immune responseChronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cellsCostimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis CThe PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptorsCrystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2cDNA Sequence and Fab Crystal Structure of HL4E10, a Hamster IgG Lambda Light Chain Antibody Stimulatory for γδ T CellsStructure and Interactions of the Human Programmed Cell Death 1 Receptor
P2860
Q24305180-024AF61B-43A7-486D-B9E2-A875D6D15199Q24310297-D6B96F9B-E752-4C51-BEBC-67A7A80A3C24Q24535835-74A123BF-1594-44D3-AB60-907E42C407E0Q24613354-C6D6F5DA-54E1-474A-B9E2-4BD20E136C81Q24615454-632AD67B-BA8C-4D6C-9631-D059263B5AB9Q24633549-F162D17A-C1D9-43F7-B24E-B1FF507662E0Q24634293-0E671829-801D-48A8-A220-56A51C86F878Q24655393-3ECD272B-1701-4BF2-B547-40573DD2A4B5Q24670319-AF729D87-C110-4A13-AE1D-FA6F4C322AA9Q24670363-905B16E9-DBFE-4419-A1C2-523A554EBD49Q24673269-B3E217FD-2E17-42DD-B284-13963182C13DQ24675931-5539F85B-82C2-4A8F-8A0D-7E00FCF9C5C6Q24677367-C6619BA1-DC20-483E-AE42-5404CF7D64FBQ26738671-F4BA4DE5-A36E-4955-B9BB-1607AA15D900Q26740988-141A9A07-7777-40C4-A454-F951AD8DB8FBQ26745516-5CB0632A-AB88-4AC1-BB80-443DFE92B8C8Q26745842-840F691B-D019-4A3E-AF46-2A8A08235F8FQ26748775-AB02D6FA-1466-4848-92A1-800EFE1AFA55Q26773314-B897EC99-4592-46D6-A680-3ECCA38F8057Q26777394-5B8E7ADB-40C5-4706-8A54-C2EAB6763EADQ26781481-DBC88F61-3ACF-45E1-AFC5-C913BC9877CAQ26786108-16323101-0B90-4763-B789-A459F1F27257Q26796435-57C97826-44D4-4BBF-BCA9-CFB10B2F83C0Q26798330-A84BB531-FB14-4D1F-861D-3004B180532CQ26799812-5159281E-57AB-4264-B85F-DC4AA5B4DE9AQ26828748-87CD5D78-56FE-4472-8061-92E690CE0B19Q26829847-8B667572-17F3-46AA-9987-FC653CBE8747Q26830509-6391E292-109E-43E8-AF69-953E0161960EQ26853453-F322C8F0-024B-466E-A8E1-EA77B7222C31Q26865532-B71D8E5C-DCA4-41B7-BB6E-023857A1226EQ26865789-60934E16-C9AA-4F7B-A1D7-FE02410E1D75Q26997105-FC881738-250C-4FE0-B914-DC16CCB20423Q27008423-D3636184-E191-46D0-ABA7-C37D929FDB95Q27022027-7BDE7FFF-0182-4A24-9F5E-3F95C9E824CCQ27304435-E8E1730B-2D9A-413F-AE71-FF376AB70454Q27490355-9A3C48C8-7E13-419C-8134-ED8940580497Q27649885-CA1C8342-FE2E-4133-BB37-AE139532CBB2Q27651269-6ECE38CA-4499-4DF3-897E-76BABB4D99ADQ27668110-7EF879E7-6D55-4386-A79A-F8EDAFCFAE8CQ27676419-1F05E481-55F9-4C20-8B87-E744177E93CA
P2860
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Development of lupus-like auto ...... motif-carrying immunoreceptor
@ast
Development of lupus-like auto ...... motif-carrying immunoreceptor
@en
Development of lupus-like auto ...... motif-carrying immunoreceptor
@nl
type
label
Development of lupus-like auto ...... motif-carrying immunoreceptor
@ast
Development of lupus-like auto ...... motif-carrying immunoreceptor
@en
Development of lupus-like auto ...... motif-carrying immunoreceptor
@nl
prefLabel
Development of lupus-like auto ...... motif-carrying immunoreceptor
@ast
Development of lupus-like auto ...... motif-carrying immunoreceptor
@en
Development of lupus-like auto ...... motif-carrying immunoreceptor
@nl
P2093
P3181
P1433
P1476
Development of lupus-like auto ...... motif-carrying immunoreceptor
@en
P2093
P304
P3181
P356
10.1016/S1074-7613(00)80089-8
P407
P577
1999-08-01T00:00:00Z